TY  - GEN
AU  - Qian,Chongsheng
AU  - Campidelli,Arnaud
AU  - Wang,Yingying
AU  - Cai,Huili
AU  - Venard,Véronique
AU  - Jeulin,Hélène
AU  - Dalle,Jean Hugues
AU  - Pochon,Cécile
AU  - D'aveni,Maud
AU  - Bruno,Benedicte
AU  - Paillard,Catherine
AU  - Vigouroux,Stéphane
AU  - Jubert,Charlotte
AU  - Ceballos,Patrice
AU  - Marie-Cardine,Aude
AU  - Galambrun,Claire
AU  - Cholle,Clément
AU  - Clerc Urmes,Isabelle
AU  - Petitpain,Nadine
AU  - De Carvalho Bittencourt,Marcelo
AU  - Decot,Véronique
AU  - Reppel,Loïc
AU  - Salmon,Alexandra
AU  - Clement,Laurence
AU  - Bensoussan,Danièle
TI  - Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial
SN  - 1756-8722
PY  - 2018///0112
KW  - Adenovirus Infections, Human
KW  - blood
KW  - Adenoviruses, Human
KW  - immunology
KW  - Adolescent
KW  - Adult
KW  - Allografts
KW  - Child
KW  - Cord Blood Stem Cell Transplantation
KW  - Female
KW  - Graft vs Host Disease
KW  - drug therapy
KW  - Humans
KW  - Immunomagnetic Separation
KW  - Immunosuppressive Agents
KW  - adverse effects
KW  - Immunotherapy, Adoptive
KW  - methods
KW  - Interferon-gamma
KW  - metabolism
KW  - Leukapheresis
KW  - Male
KW  - T-Cell Antigen Receptor Specificity
KW  - T-Lymphocyte Subsets
KW  - Tissue Donors
KW  - Transplantation, Haploidentical
KW  - Treatment Outcome
KW  - Viral Load
KW  - Viremia
KW  - therapy
KW  - Virus Activation
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1186/s13045-017-0469-0
ER  -